Corporate Partners (2009)

As the leading professional organization in this field, the Society of Surgical Oncology acknowledges that collaboration and partnership with industry is important. This cooperation gives sponsors and donors the opportunity to assist the Society with the development of best practices in surgical oncology, and in turn, increases visibility of the company and products to physicians involved in oncologic patient care.

To discuss how your company and SSO could benefit from such a partnership, contact M. Eileen Widmer, SSO Executive Director, at 847-427-1400.

The Society thanks these companies for supporting membership services and activities at its Annual Cancer Symposium and throughout the year. (The links below do not imply endorsement by SSO leadership or membership of any particular product or service represented thereby.)

Amgen

AngioDynamics

AstraZeneca LP

Bristol-Myers Squibb Company

Covidien

Eli Lilly and Company

Ethicon Endo-Surgery, Inc., a Johnson & Johnson Company

Genentech

Genomic Health, Inc.

Hologic

ImClone Systems

IntraOp Medical Corporation

MDS Nordion

Myriad Genetic Laboratories, Inc.

Onyx Pharmaceuticals / Bayer Healthcare Pharmaceuticals

Schering-Plough Corp.

Varian Medical Systems